The smallpox threat: A time to reconsider global policy

Biosecurity and Bioterrorism

Volumn 12, Issue 3, 2014, Pages 117-121

  Henderson, D A ^a   Arita, Isao ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; SMALLPOX VACCINE;

ADVISORY COMMITTEE; BIOLOGICAL WARFARE; EPIDEMIC; FOWLPOX VIRUS; HEALTH CARE POLICY; HISTORY; HUMAN; INTERNATIONAL COOPERATION; ISOLATION AND PURIFICATION; NOTE; SMALLPOX;

ADVISORY COMMITTEES; ANTIVIRAL AGENTS; AVIPOXVIRUS; BIOTERRORISM; DISEASE OUTBREAKS; HEALTH POLICY; HISTORY, 20TH CENTURY; HUMANS; INTERNATIONALITY; SMALLPOX; SMALLPOX VACCINE;

EID: 84900025994     PISSN: 15387135     EISSN: None     Source Type: Journal    
DOI: 10.1089/bsp.2014.1509.comm     Document Type: Note

References (14)

1. World Health Organization. Smallpox Eradication: Destruction of Variola Virus Stocks. WHA document 64.11. Geneva: World Health Organization; 2011.
2. Henderson DA. Smallpox virus destruction and the implications of a new vaccine. Biosecur Bioterror 2011;9(2):163-168.
3. Arita I. The Smallpox Eradication Saga. Hyderabad, India: Orient Blackswan; 2010:16-20.
4. World Health Organization. Final Report of the Global Commission for the Certification of Smallpox Eradication. Geneva: World Health Organization; 1980.
5. Tucker JB. Breaking the deadlock over destruction of the smallpox virus stocks. Biosecur Bioterror 2011;9:1-13.
6. World Health Organization. Advisory Committee on Variola Virus Research. Report of the Twelfth Meeting. Geneva: World Health Organization; 2013.
7. World Health Organization. Advisory Group of Independent Experts to Review the Smallpox Research Programme (AGIES). Geneva: World Health Organization; 2013.
8. World Health Organization. Scientific Review of Variola Virus Research 1999-2010. Geneva: World Health Organization; 2010.
9. Alibek K, Handelman S. Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World. New York: Random House; 1999.
10. World Health Organization. Working Document: Mechanisms for Acquisition and Release of Smallpox Vaccine by WHO. Geneva: World Health Organization; 2004.
11. Kennedy JS, Gurwith M, Dekker CL, et al. Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-näve adults. J Infect Dis 2011;204:1395-1402.
12. World Health Organization. Meeting of the Strategic Advisory Group of Experts on Immunization 2013. Conclusions and Recommendations. Wkly Epidemiol Rec 2014;89:1-2.
13. Ruepp R. European Medicines Agency Activities on Smallpox. Paper prepared for the WHO Advisory Committee on Variola Virus Research, September 2013.
14. Hatch GJ, Graham VA, Bewley KR, et al. Assessment of the protective effect of Imvamune and Acam2000 vaccines against aerosolized monkeypox virus in cynomolgus macaques. J Virol 2013;87:7805-7815.